Add to My Stocks
$8.57 $0.02 (0.23%) ITRM stock closing price Sep 18, 2018 (Closing)
Fiscal year is Jan - Dec2018 Q2
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow-
Net Increase (Decrease) in Assets Liabilities2.61M
Cash From (used in) Discontinued Operations-
Other Adjustments Net-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.05M
Acquisition Disposition of Subsidiaires-
Increase (Decrease) in Investments-19.58M
Other Cash Inflow (Outflow) from Investment Activities-
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares106.33M
Issuance (Repayment) of Debt Securities14.51M
Increase (Decrease) in Bank & Other Borrowings-
Payment of Dividends & Other Cash Distributions-
Other Cash from (used by) Financing Activities-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year8.49M
Cash & Equivalents at Year End85.02M
All figures in USD. M: Millions of USD, B: Billions of USD.

Key Financial Ratios For ITERUM THERAPTC Cash Flow

Quarterly Cash Flow Statements For ITERUM THERAPTC Peers

Infinity Pharma cash flow, Steadymed cash flow